Globe Trade Centre SA
JSE:GTC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Globe Trade Centre SA
JSE:GTC
|
PL |
|
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
|
US |
|
C
|
CULT Food Science Corp
CNSX:CULT
|
CA |
Balance Sheet
Balance Sheet Decomposition
Globe Trade Centre SA
Globe Trade Centre SA
Balance Sheet
Globe Trade Centre SA
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
43
|
37
|
85
|
62
|
277
|
344
|
202
|
186
|
192
|
141
|
229
|
130
|
81
|
169
|
150
|
149
|
80
|
180
|
272
|
87
|
115
|
60
|
53
|
|
| Cash Equivalents |
43
|
37
|
85
|
62
|
277
|
344
|
202
|
186
|
192
|
141
|
229
|
130
|
81
|
169
|
150
|
149
|
80
|
180
|
272
|
87
|
115
|
60
|
53
|
|
| Short-Term Investments |
16
|
9
|
9
|
14
|
8
|
14
|
27
|
30
|
38
|
37
|
26
|
29
|
32
|
27
|
28
|
53
|
30
|
33
|
27
|
14
|
13
|
17
|
27
|
|
| Total Receivables |
7
|
6
|
13
|
41
|
31
|
36
|
47
|
44
|
32
|
20
|
12
|
10
|
9
|
12
|
24
|
13
|
17
|
17
|
10
|
136
|
20
|
20
|
28
|
|
| Accounts Receivables |
5
|
4
|
3
|
27
|
17
|
8
|
6
|
10
|
9
|
5
|
6
|
6
|
6
|
7
|
6
|
5
|
6
|
12
|
7
|
10
|
12
|
16
|
20
|
|
| Other Receivables |
2
|
2
|
10
|
14
|
14
|
29
|
41
|
33
|
24
|
15
|
5
|
4
|
2
|
5
|
18
|
7
|
11
|
4
|
3
|
127
|
7
|
5
|
8
|
|
| Inventory |
21
|
13
|
17
|
32
|
116
|
212
|
325
|
272
|
202
|
106
|
82
|
41
|
24
|
3
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
0
|
1
|
2
|
3
|
32
|
31
|
10
|
5
|
5
|
3
|
3
|
2
|
1
|
3
|
3
|
1
|
2
|
4
|
304
|
67
|
78
|
201
|
|
| Total Current Assets |
88
|
65
|
126
|
150
|
434
|
639
|
632
|
541
|
470
|
308
|
352
|
212
|
147
|
213
|
210
|
220
|
129
|
232
|
313
|
542
|
215
|
176
|
309
|
|
| PP&E Net |
62
|
37
|
139
|
127
|
170
|
285
|
1
|
1
|
55
|
76
|
75
|
83
|
43
|
28
|
20
|
20
|
19
|
22
|
18
|
35
|
38
|
43
|
51
|
|
| PP&E Gross |
62
|
37
|
139
|
127
|
170
|
285
|
1
|
1
|
55
|
76
|
75
|
83
|
43
|
28
|
20
|
20
|
19
|
22
|
18
|
35
|
38
|
43
|
51
|
|
| Accumulated Depreciation |
3
|
3
|
3
|
3
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
2
|
2
|
3
|
3
|
2
|
2
|
2
|
3
|
3
|
4
|
4
|
6
|
|
| Goodwill |
0
|
0
|
0
|
14
|
9
|
8
|
1
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
5
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
11
|
11
|
11
|
11
|
12
|
12
|
|
| Long-Term Investments |
403
|
311
|
354
|
593
|
577
|
905
|
1 941
|
2 083
|
2 198
|
1 766
|
1 685
|
1 457
|
1 317
|
1 312
|
1 608
|
1 938
|
2 113
|
2 247
|
2 125
|
2 241
|
2 374
|
2 409
|
2 829
|
|
| Other Long-Term Assets |
4
|
1
|
6
|
10
|
14
|
15
|
4
|
6
|
8
|
141
|
50
|
4
|
10
|
7
|
1
|
4
|
85
|
12
|
13
|
16
|
32
|
17
|
23
|
|
| Other Assets |
0
|
0
|
0
|
14
|
9
|
8
|
1
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
558
N/A
|
414
-26%
|
625
+51%
|
894
+43%
|
1 208
+35%
|
1 853
+53%
|
2 579
+39%
|
2 631
+2%
|
2 734
+4%
|
2 291
-16%
|
2 162
-6%
|
1 756
-19%
|
1 517
-14%
|
1 560
+3%
|
1 839
+18%
|
2 183
+19%
|
2 357
+8%
|
2 523
+7%
|
2 481
-2%
|
2 844
+15%
|
2 670
-6%
|
2 657
0%
|
3 224
+21%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
12
|
4
|
18
|
20
|
42
|
40
|
67
|
86
|
57
|
52
|
34
|
27
|
20
|
29
|
37
|
51
|
50
|
37
|
27
|
31
|
41
|
34
|
63
|
|
| Accrued Liabilities |
3
|
1
|
9
|
6
|
32
|
41
|
47
|
1
|
20
|
2
|
35
|
22
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
2
|
0
|
3
|
2
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
20
|
12
|
16
|
17
|
48
|
30
|
51
|
60
|
83
|
262
|
195
|
169
|
120
|
80
|
154
|
126
|
122
|
226
|
194
|
45
|
49
|
45
|
220
|
|
| Other Current Liabilities |
0
|
2
|
5
|
12
|
28
|
62
|
62
|
45
|
29
|
29
|
67
|
32
|
4
|
21
|
5
|
11
|
9
|
7
|
10
|
6
|
8
|
5
|
106
|
|
| Total Current Liabilities |
35
|
20
|
50
|
55
|
153
|
175
|
244
|
192
|
189
|
344
|
330
|
251
|
145
|
131
|
196
|
189
|
183
|
272
|
232
|
84
|
100
|
86
|
391
|
|
| Long-Term Debt |
259
|
169
|
251
|
339
|
267
|
595
|
934
|
1 238
|
1 298
|
1 021
|
921
|
790
|
803
|
659
|
739
|
908
|
993
|
1 027
|
1 111
|
1 294
|
1 231
|
1 272
|
1 427
|
|
| Deferred Income Tax |
9
|
9
|
7
|
35
|
54
|
93
|
156
|
118
|
127
|
123
|
120
|
120
|
130
|
133
|
98
|
126
|
139
|
147
|
133
|
140
|
141
|
135
|
137
|
|
| Minority Interest |
1
|
1
|
8
|
1
|
0
|
29
|
58
|
47
|
44
|
20
|
17
|
46
|
62
|
21
|
3
|
4
|
5
|
14
|
17
|
16
|
23
|
24
|
49
|
|
| Other Liabilities |
2
|
1
|
2
|
4
|
4
|
6
|
81
|
69
|
65
|
85
|
47
|
19
|
12
|
15
|
16
|
19
|
20
|
18
|
30
|
208
|
62
|
37
|
93
|
|
| Total Liabilities |
306
N/A
|
200
-35%
|
318
+59%
|
433
+36%
|
479
+10%
|
899
+88%
|
1 471
+64%
|
1 664
+13%
|
1 723
+4%
|
1 553
-10%
|
1 402
-10%
|
1 134
-19%
|
1 028
-9%
|
917
-11%
|
1 052
+15%
|
1 246
+18%
|
1 341
+8%
|
1 478
+10%
|
1 523
+3%
|
1 743
+14%
|
1 557
-11%
|
1 555
0%
|
2 096
+35%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
4
|
4
|
4
|
5
|
5
|
6
|
5
|
5
|
6
|
5
|
8
|
8
|
8
|
10
|
10
|
11
|
11
|
11
|
11
|
11
|
13
|
13
|
13
|
|
| Retained Earnings |
216
|
183
|
199
|
343
|
492
|
707
|
740
|
618
|
681
|
345
|
290
|
147
|
120
|
136
|
279
|
406
|
461
|
487
|
411
|
573
|
441
|
422
|
421
|
|
| Additional Paid In Capital |
32
|
27
|
100
|
118
|
221
|
295
|
247
|
250
|
259
|
230
|
354
|
347
|
364
|
499
|
499
|
521
|
547
|
551
|
551
|
551
|
669
|
669
|
669
|
|
| Other Equity |
0
|
0
|
4
|
6
|
12
|
54
|
116
|
95
|
66
|
159
|
109
|
120
|
3
|
3
|
2
|
0
|
3
|
4
|
14
|
33
|
10
|
2
|
25
|
|
| Total Equity |
252
N/A
|
214
-15%
|
306
+43%
|
461
+50%
|
729
+58%
|
955
+31%
|
1 108
+16%
|
967
-13%
|
1 011
+4%
|
738
-27%
|
761
+3%
|
622
-18%
|
489
-21%
|
643
+31%
|
787
+23%
|
937
+19%
|
1 016
+8%
|
1 045
+3%
|
958
-8%
|
1 101
+15%
|
1 113
+1%
|
1 102
-1%
|
1 128
+2%
|
|
| Total Liabilities & Equity |
558
N/A
|
414
-26%
|
625
+51%
|
894
+43%
|
1 208
+35%
|
1 853
+53%
|
2 579
+39%
|
2 631
+2%
|
2 734
+4%
|
2 291
-16%
|
2 162
-6%
|
1 756
-19%
|
1 517
-14%
|
1 560
+3%
|
1 839
+18%
|
2 183
+19%
|
2 357
+8%
|
2 523
+7%
|
2 481
-2%
|
2 844
+15%
|
2 670
-6%
|
2 657
0%
|
3 224
+21%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
166
|
165
|
221
|
222
|
242
|
244
|
244
|
244
|
244
|
244
|
325
|
325
|
357
|
460
|
460
|
470
|
484
|
486
|
486
|
486
|
574
|
574
|
574
|
|